1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
TRex Bio Inc.

TRex Bio Inc.

TRXB
TRex Bio Inc.US flagNASDAQ
14.01
USD
-0.15
- -
116.70MMarket Cap
TRex Bio Inc.
TRXB
(NASDAQ)

Recent

price

14.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Progressive Care, Inc. (RXMD)
Sanai Health Industry Group Company Limited (1889.HK)
Universal Health International Group Holding Limited (2211.HK)
Relevium Technologies Inc. (RLLVF)
Noveris Health Sciences Inc. (MYCOF)
Link Reservations Inc. (LRSV)
Business
Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.

Company News

Company News APIChatGPT